Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Investment
    • China's Ping An...

    China's Ping An Ventures to raise up to 1.3 billion dollars for healthcare investments: source

    Written by Ruby Khatun Khatun Published On 2018-02-10T09:30:32+05:30  |  Updated On 10 Feb 2018 9:30 AM IST
    Chinas Ping An Ventures to raise up to 1.3 billion dollars for healthcare investments: source

    HONG KONG: The venture capital arm of China's largest insurer, Ping An, is targeting raising up to $1.3 billion in two healthcare-focused funds that will seek growth-stage and pre-IPO investments, said a person with direct knowledge of the matter.


    Ping An Ventures, set up in 2012, focused on early-stage investments in its first few years. The new funds will deepen the group's push into the healthcare sector and build up its firepower for later-stage investments, at a time when valuations in the fast-growing tech and healthcare industries have spiked.


    The venture capital firm aims to raise $300 million to $500 million in a dollar-denominated fund and 4 billion yuan to 5 billion yuan ($640 million-$800 million) in a yuan fund, the person said. They would be Ping An Ventures' biggest dollar and yuan funds so far and would primarily invest in healthcare start-ups at home and overseas, the person added.


    Ping An Ventures, whose investments include ride-hailing firm Didi Chuxing, has tapped prospective investors, including wealth management firms and institutional investors, for the new funds, the person said. The fundraising is expected to be completed within this year, the source added.


    Ping An didn't respond to requests for comment. The person declined to be named as the information was confidential.


    The fundraising plans come as the average value of late-stage investments globally surged 40 percent last year, according to data provider Preqin. Investments of $100 million-plus made up more than half of all global VC fundraising by value in 2017, versus barely 8 percent in 2007, Preqin data showed.


    The plans also come as Ping An Insurance Group Co of China, China's largest insurer by market value, is looking to boost its direct investments and expertise in the healthcare industry.


    Two Ping An healthcare-related units plan to go public in Hong Kong this year - Ping An Good Doctor, an online medical platform which allows users to consult doctors for diagnosis, and Ping An Healthcare Technology, a medical data collection, and analysis business.


    The latter last week completed a $1.15 billion pre-IPO fundraising round, Ping An said. That valued it at about $8.8 billion, according to sources.


    Last year Shenzhen-based Ping An launched a Hong Kong-based $1 billion fund, called Global Voyager, to scout for healthcare and fintech assets in the United States, Israel, and Singapore.


    Ping An Ventures operates separately from Global Voyager, and apart from generating returns, seeks to use the acquired technology and know-how to help its parent develop its business in China.


    It has more than 100 portfolio investments including domestic on-demand services provider Meituan-Dianping, New York-based Oscar Health Insurance and online payment platform Payoneer and Philadelphia-headquartered biotherapeutics firm Tmunity Therapeutics.


    (Reporting by Julie ZhuEditing by Muralikumar Anantharaman)

    chinafund raisinghealthcare investmentsHealthcare sectorInvestmentsIPOPing An Venturesraise
    Source : REUTERS

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok